BBIO
Price
$23.41
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
One day until earnings call
BPMC
Price
$87.51
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
102 days until earnings call
Ad is loading...

BBIO vs BPMC

Header iconBBIO vs BPMC Comparison
Open Charts BBIO vs BPMCBanner chart's image
BridgeBio Pharma
Price$23.41
Change-$0.00 (-0.00%)
Volume$5.43K
CapitalizationN/A
Blueprint Medicines
Price$87.51
Change-$0.00 (-0.00%)
Volume$4.48K
CapitalizationN/A
View a ticker or compare two or three
BBIO vs BPMC Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BBIO vs. BPMC commentary
Nov 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a Hold and BPMC is a Hold.

COMPARISON
Comparison
Nov 03, 2024
Stock price -- (BBIO: $23.41 vs. BPMC: $87.51)
Brand notoriety: BBIO and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 0% vs. BPMC: 1%
Market capitalization -- BBIO: $4.79B vs. BPMC: $5.76B
BBIO [@Biotechnology] is valued at $4.79B. BPMC’s [@Biotechnology] market capitalization is $5.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 3 TA indicator(s) are bullish while BPMC’s TA Score has 6 bullish TA indicator(s).

  • BBIO’s TA Score: 3 bullish, 5 bearish.
  • BPMC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than BBIO.

Price Growth

BBIO (@Biotechnology) experienced а -1.80% price change this week, while BPMC (@Biotechnology) price change was +6.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BBIO is expected to report earnings on Feb 20, 2025.

BPMC is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.76B) has a higher market cap than BBIO($4.79B). BPMC YTD gains are higher at: -5.128 vs. BBIO (-42.011). BPMC has higher annual earnings (EBITDA): -159.72M vs. BBIO (-368.14M). BPMC has more cash in the bank: 764M vs. BBIO (448M). BPMC has less debt than BBIO: BPMC (475M) vs BBIO (1.73B). BPMC has higher revenues than BBIO: BPMC (363M) vs BBIO (219M).
BBIOBPMCBBIO / BPMC
Capitalization4.79B5.76B83%
EBITDA-368.14M-159.72M230%
Gain YTD-42.011-5.128819%
P/E RatioN/AN/A-
Revenue219M363M60%
Total Cash448M764M59%
Total Debt1.73B475M364%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOBPMC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 5 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 10 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQJG22.940.21
+0.92%
Invesco ESG NASDAQ Next Gen 100 ETF
TDVI24.420.16
+0.64%
FT Cboe Vest Tech Div Trgt Inc ETF
IBMN26.570.01
+0.02%
iShares iBonds Dec 2025 Term Muni Bd ETF
IFRA46.90N/A
N/A
iShares US Infrastructure ETF
PCGG11.31N/A
N/A
Polen Capital Global Growth ETF

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with BPMC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
N/A
BPMC - BBIO
48%
Loosely correlated
N/A
ARGX - BBIO
46%
Loosely correlated
+1.58%
AXON - BBIO
44%
Loosely correlated
N/A
ARRY - BBIO
43%
Loosely correlated
+2.60%
NAUT - BBIO
43%
Loosely correlated
N/A
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with SNDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
N/A
SNDX - BPMC
46%
Loosely correlated
+0.64%
BBIO - BPMC
45%
Loosely correlated
N/A
ORMP - BPMC
44%
Loosely correlated
N/A
INZY - BPMC
43%
Loosely correlated
N/A
BEAM - BPMC
43%
Loosely correlated
N/A
More